Sale!

Plasmacytosis Test Cost

Original price was: 3,600 د.إ.Current price is: 2,700 د.إ.

-25%

Plasmacytosis Test at DNA Labs UAE

The Plasmacytosis Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to measure the levels of plasma cells in the blood. Plasma cells are a type of white blood cell that plays a crucial role in the immune system by producing antibodies to fight off infections. However, an abnormal increase in plasma cells can be indicative of various medical conditions, including multiple myeloma, a type of blood cancer, or other plasma cell disorders.

At DNA Labs UAE, the test is conducted with precision and accuracy, employing the latest technology and methodologies to ensure reliable results. The cost of the Plasmacytosis Test is 2700 AED, reflecting the comprehensive nature of the analysis and the state-of-the-art facilities used in the process.

Individuals undergoing this test at DNA Labs UAE can expect a thorough examination of their blood sample, with results providing critical insights into their plasma cell levels. This information is vital for diagnosing conditions related to abnormal plasma cell production, enabling healthcare providers to formulate appropriate treatment plans.

DNA Labs UAE is renowned for its commitment to excellence in diagnostic services, making it a trusted choice for patients seeking advanced testing solutions, including the Plasmacytosis Test.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Plasmcytosis Test Cost AED: 2700.0 – Symptoms, Diagnosis, and More

Test Details

Plasmacytosis is a condition characterized by an increase in the number of plasma cells in the blood or bone marrow. Plasma cells are a type of white blood cell that produce antibodies to help fight infection. In plasmacytosis, there is an abnormal proliferation of plasma cells, leading to an excess production of antibodies. Plasmacytosis is commonly associated with plasma cell disorders, such as multiple myeloma or monoclonal gammopathy of undetermined significance (MGUS).

Multiple myeloma is a cancer of plasma cells, while MGUS is a precursor condition that may progress to multiple myeloma. The symptoms of plasmacytosis can vary depending on the underlying condition. In multiple myeloma, symptoms may include bone pain, fatigue, anemia, frequent infections, and kidney problems. MGUS may not cause any symptoms and is often discovered incidentally during routine blood tests.

Test Name

Plasmcytosis Test

Components

  • EDTA Vacutainer (2ml)
  • Sodium heparin Vacutainer (2ml)

Price

2700.0 AED

Sample Condition

Bone Marrow

Report Delivery

1-2 days

Method

Flowcytometry

Test Type

Genetics

Doctor

General Surgeon

Test Department

Not specified

Pre Test Information

Plasmcytosis can be done with a doctor’s prescription. Prescription is not applicable for surgery and pregnancy cases or people planning to travel abroad.

Treatment

Treatment for plasmacytosis depends on the underlying condition. In multiple myeloma, treatment may involve chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. MGUS may not require treatment, but regular monitoring is necessary to detect any progression to multiple myeloma. It is important to consult with a healthcare professional for an accurate diagnosis and appropriate management of plasmacytosis.

Test Name Plasmcytosis Test
Components EDTA Vacutainer (2ml)/Sodium heparin Vacutainer (2ml)
Price 2700.0 AED
Sample Condition Bone Marrow
Report Delivery 1-2 days
Method Flowcytometry
Test type Genetics
Doctor General Surgeon
Test Department:
Pre Test Information Plasmcytosis can be done with a Doctors prescription. Prescription is not applicable for surgery and pregnancy cases or people planing to travel abroad.
Test Details

Plasmacytosis is a condition characterized by an increase in the number of plasma cells in the blood or bone marrow. Plasma cells are a type of white blood cell that produce antibodies to help fight infection. In plasmacytosis, there is an abnormal proliferation of plasma cells, leading to an excess production of antibodies.

Plasmacytosis is commonly associated with plasma cell disorders, such as multiple myeloma or monoclonal gammopathy of undetermined significance (MGUS). Multiple myeloma is a cancer of plasma cells, while MGUS is a precursor condition that may progress to multiple myeloma.

The symptoms of plasmacytosis can vary depending on the underlying condition. In multiple myeloma, symptoms may include bone pain, fatigue, anemia, frequent infections, and kidney problems. MGUS may not cause any symptoms and is often discovered incidentally during routine blood tests.

Treatment for plasmacytosis depends on the underlying condition. In multiple myeloma, treatment may involve chemotherapy, radiation therapy, stem cell transplantation, and targeted therapies. MGUS may not require treatment, but regular monitoring is necessary to detect any progression to multiple myeloma.

It is important to consult with a healthcare professional for an accurate diagnosis and appropriate management of plasmacytosis.